Abstract:AIM:To investigate the role of bone marrow-derived endothelial progenitor cells（EPCs） in the angiogenesis of hepatocellular carcinoma（HCC）.METHODS:The bone marrow of HCC mice was reconstructed by transplanting green fluorescent protein（GFP） + bone marrow cells.The concentration of circulating EPCs was determined by colony-forming assays and fluorescence-activated cell sorting.Serum and tissue levels of vascular endothelial growth factor（VEGF） and colony-stimulating factor（CSF） were quantified by enzyme-linked immunosorbent assay.The distribution of EPCs in tumor and tumor-free tissues was detected by immunohistochemistry and real-time polymerase chain reaction.The incorporation of EPCs into hepatic vessels was examined by immunofluorescence and immunohistochemistry.The proportion of EPCs in vessels was then calculated.RESULTS:The HCC model was successful established.The flow cytometry analysis showed the mean percentage of CD133CD34 and CD133VEGFR2 double positive cells in HCC mice was 0.45% ± 0.16% and 0.20% ± 0.09% respectively.These values are much higher than in the sham-operation group（0.11% ± 0.13%,0.05% ± 0.11%,n = 9） at 14 d after modeling.At 21 d,the mean percentage of circulating CD133CD34 and CD133VEGFR2 cells is 0.23% ± 0.19%,0.25% ± 0.15% in HCC model vs 0.05% ± 0.04%,0.12% ± 0.11% in control.Compared to the transient increase observed in controls,the higher level of circulating EPCs were induced by HCC.In addition,the level of serum VEGF and CSF increased gradually in HCC,reaching its peak 14 d after modeling,then slowly decreased.Consecutive sections stained for the CD133 and CD34 antigens showed that the CD133+ and CD34+ VEGFR2 cells were mostly recruited to HCC tissue and concentrated in tumor microvessels.Under fluorescence microscopy,the bone-marrow（BM）-derived cells labeled with GFP were concentrated in the same area.The relative levels of CD133 and CD34 gene expression were elevated in tumors,around 5.0 and 3.8 times that of the tumor free area.In frozen liver sections from HCC mice,cells co-expressing CD133 and VEGFR2 were identified by immunohistochemical staining using anti-CD133 and VEGFR2 antibodies.In tumor tissue,the double-positive cells were incorporated into vessel walls.In immunofluorescent staining.These CD31 and GFP double positive cells are direct evidence that tumor vascular endothelial cells（VECs） come partly from BM-derived EPCs.The proportion of GFP CD31 double positive VECs（out of all VECs） on day 21 was around 35.3% ± 21.2%.This is much higher than the value recorded on day 7 group（17.1% ± 8.9%）.The expression of intercellular adhesion molecule 1,vascular adhesion molecule 1,and VEGF was higher in tumor areas than in tumor-free tissues.CONCLUSION:Mobilized EPCs were found to participate in tumor vasculogenesis of HCC.Inhibiting EPC mobilization or recruitment to tumor tissue may be an efficient strategy for treating HCC.

LIVER ISCHEMIA/REPERFUSION INJURY INDUCES THE MOBILIZATION OF ENDOTHELIAL PROGENITOR CELLS

Norepinephrine Stimulates Mobilization of Endothelial Progenitor Cells after Limb Ischemia

The renoprotective effect of bone marrow-derived endothelial progenitor cell transplantation on acute ischemia-reperfusion injury in rats.

Experimental study on repairment effect of endothelial progenitor cells after focal cerebral ischemia in rats

In vivo tracking of PKH26-1abeled endothelial progenitor cells after transplantation into rats with chronic liver injury

VEGF and Ang-1 Promotes Endothelial Progenitor Cells Homing in the Rat Model of Renal Ischemia and Reperfusion Injury.

INTRAVENOUS DELIVERY OF BONE MARROW-DERIVED ENDOTHELIAL PROGENITOR CELLS IMPROVES SURVIVAL AND ATTENUATES LIPOPOLYSACCHARIDE-INDUCED LUNG INJURY IN RATS

Intravenous Transfusion of Endothelial Progenitor Cells in Rats with Acute Myocardial Infarction

The Repair Function of United Endothelial Progenitor Cells Transplantation on Injured Liver Endothelium by Bone Marrow Transplantation Conditioning

Research of improving ischemia flap survival rate by transplanting endothelial progenitor cells of bone marrow vascular

Changes of Bonemarrow and Circulating Endothelial Progenitor Cells in Mice with Acute Pancreatitis

Study on Hepatic Ischemia and Reperfusion (I/R) Injury in Rats

Hepatic Vascular Endothelial Growth Factor Regulates Recruitment of Rat Liver Sinusoidal Endothelial Cell Progenitor Cells.

In Vivo Serial Mr Imaging of Magnetically Labeled Endothelial Progenitor Cells Homing to the Endothelium Injured Artery in Mice

Impact of ischemic preconditioning on dynamics of homing of endothelial progenitor cells after renal ischemia reperfusion injury

Transplantation of Endothelial Progenitor Cells from Peripheral Blood Enhancing Neovascularization in Ischemic Tissue of Nude Mice

Anti-apoptosis Role of Endothelial Progenitor Cells in the Eraly Phase of Acute Renal Ischemia Reperfusion Injury

Exogenous Vascular Endothelial Growth Factor Delivery Prior to Endothelial Precursor Cell Transplantation in Orthotopic Liver Transplantation-Induced Hepatic Ischemia/Reperfusion Injury

Endothelial Precursor Cells Promote Angiogenesis in Hepatocellular Carcinoma

Involvement of Stromal Cell-Derived Factor-1-CXCR4 Axis in Recruitment of Endothelial Progenitor Cell and Reendotheliazation After Vascular Injury in Mice

Noninvasive Evaluation of the Migration Effect of Transplanted Endothelial Progenitor Cells in Ischemic Muscle Using a Multimodal Imaging Agent